Generation of monospecific antibodies based on affinity capture of polyclonal antibodies

Barbara Hjelm1, Björn Forsström, Ulrika Igel

  • 1Department of Biotechnology, AlbaNova University Center, Royal Institute of Technology, 10691 Stockholm, Sweden.

Insights

Researchers developed a method to create highly specific antibodies by mapping epitopes on polyclonal antibodies. This approach generates functional, epitope-specific antibodies essential for human proteome characterization and cancer research.

Area of Science:

  • Immunology
  • Proteomics
  • Cancer Biology

Background:

  • Polyclonal antibodies are crucial tools in biological research but often lack specificity.
  • Characterizing the human proteome requires highly specific and validated antibodies.

Purpose of the Study:

  • To develop a method for generating and validating epitope-specific antibodies.
  • To assess the functionality of antibodies targeting different epitopes of specific proteins.

Main Methods:

  • Mapping linear epitopes of polyclonal antibodies using synthetic peptides.
  • Generating and validating epitope-specific antibodies via sequential capture.
  • Assessing antibody functionality using Western blot, immunohistochemistry, and immunofluorescence.

Main Results:

  • Generated epitope-specific antibodies for four cancer-associated proteins: RBM3, SATB2, ANLN, and CNDP1.
  • Observed significant differences in functionality among antibodies targeting distinct epitopes.
  • Identified at least one fully functional antibody for each protein across all tested applications.

Conclusions:

  • The described method enables the generation of reliable, epitope-specific antibodies from polyclonal antibody binding sites.
  • This approach offers a robust strategy for large-scale human proteome characterization.
  • Epitope mapping is critical for developing functional antibodies for cancer research.

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Affinity and Avidity01:41

Affinity and Avidity

Overview
Affinity Chromatography01:03

Affinity Chromatography

Affinity chromatography is a powerful technique extensively utilized for separating and purifying specific biomolecules from complex mixtures. It capitalizes on the highly selective binding between an analyte and its counterpart, such as antibody-antigen interactions. The counterpart is immobilized on the stationary phase, forming an affinity column. The stationary phase typically consists of solid support, such as agarose or porous glass beads, immobilizing the affinity ligand. The mobile...
Immunoprecipitation01:20

Immunoprecipitation

Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...